Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-03

AUTHORS

Pat Whitworth, Peter Beitsch, Angela Mislowsky, James V. Pellicane, Charles Nash, Mary Murray, Laura A. Lee, Carrie L. Dul, Michael Rotkis, Paul Baron, Lisette Stork-Sloots, Femke A. de Snoo, Jennifer Beatty

ABSTRACT

PURPOSE: Hormone receptor-positive (HR+) tumors have heterogeneous biology and present a challenge for determining optimal treatment. In the Neoadjuvant Breast Registry Symphony Trial (NBRST) patients were classified according to MammaPrint/BluePrint subtyping to provide insight into the response to neoadjuvant endocrine therapy (NET) or neoadjuvant chemotherapy (NCT). OBJECTIVE: The purpose of this predefined substudy was to compare MammaPrint/BluePrint with conventional 'clinical' immunohistochemistry/fluorescence in situ hybridization (IHC/FISH) subtyping in 'clinical luminal' [HR+/human epidermal growth factor receptor 2-negative (HER2-)] breast cancer patients to predict treatment sensitivity. METHODS: NBRST IHC/FISH HR+/HER2- breast cancer patients (n = 474) were classified into four molecular subgroups by MammaPrint/BluePrint subtyping: Luminal A, Luminal B, HER2, and Basal type. Pathological complete response (pCR) rates were compared with conventional IHC/FISH subtype. RESULTS: The overall pCR rate for 'clinical luminal' patients to NCT was 11 %; however, 87 of these 474 patients were reclassified as Basal type by BluePrint, with a high pCR rate of 32 %. The MammaPrint index was highly associated with the likelihood of pCR (p < 0.001). Fifty-three patients with BluePrint Luminal tumors received NET with an aromatase inhibitor and 36 (68 %) had a clinical response. CONCLUSIONS: With BluePrint subtyping, 18 % of clinical 'luminal' patients are classified in a different subgroup, compared with conventional assessment, and these patients have a significantly higher response rate to NCT compared with BluePrint Luminal patients. MammaPrint/BluePrint subtyping can help allocate effective treatment to appropriate patients. In addition, accurate identification of subtype biology is important in the interpretation of neoadjuvant treatment response since lack of pCR in luminal patients does not portend the worse prognosis associated with residual disease in Basal and HER2 subtypes. More... »

PAGES

669-675

Identifiers

URI

http://scigraph.springernature.com/pub.10.1245/s10434-016-5600-x

DOI

http://dx.doi.org/10.1245/s10434-016-5600-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1040378989

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27770345


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anastrozole", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aromatase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bridged-Ring Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Decision-Making", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclophosphamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Docetaxel", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Doxorubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Profiling", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "In Situ Hybridization, Fluorescence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Letrozole", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mastectomy, Segmental", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Molecular Typing", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoadjuvant Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nitriles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptor, ErbB-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Estrogen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Progesterone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Registries", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tamoxifen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Taxoids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Triazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Nashville Breast Center, Nashville, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Whitworth", 
        "givenName": "Pat", 
        "id": "sg:person.07624156167.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07624156167.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dallas Surgical Group", 
          "id": "https://www.grid.ac/institutes/grid.477059.8", 
          "name": [
            "Dallas Surgical Group, Dallas, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Beitsch", 
        "givenName": "Peter", 
        "id": "sg:person.01150535406.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150535406.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Coastal Carolina Breast Center, Murrells Inlet, SC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mislowsky", 
        "givenName": "Angela", 
        "id": "sg:person.0620474121.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620474121.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Virginia Breast Center, Bon Secours Cancer Institute, Richmond, VA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pellicane", 
        "givenName": "James V.", 
        "id": "sg:person.0767224550.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767224550.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northeast Georgia Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.490329.5", 
          "name": [
            "Northeast Georgia Medical Center, Gainesville, GA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nash", 
        "givenName": "Charles", 
        "id": "sg:person.01151566350.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151566350.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Akron General Hospital, Akron, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Murray", 
        "givenName": "Mary", 
        "id": "sg:person.0762503715.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762503715.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Comprehensive Cancer Center, Palm Springs, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Laura A.", 
        "id": "sg:person.01103453150.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103453150.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "St. John Region, Grosse Pointe Woods, MI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dul", 
        "givenName": "Carrie L.", 
        "id": "sg:person.014031317265.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014031317265.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northern Indiana Cancer Research Consortium", 
          "id": "https://www.grid.ac/institutes/grid.492869.8", 
          "name": [
            "Northern Indiana Cancer Research Consortium, South Bend, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rotkis", 
        "givenName": "Michael", 
        "id": "sg:person.0604662750.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604662750.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Breast and Melanoma Specialists of Charleston, Charleston, SC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Baron", 
        "givenName": "Paul", 
        "id": "sg:person.01343475561.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01343475561.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medical Affairs, Agendia Inc, Irvine, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stork-Sloots", 
        "givenName": "Lisette", 
        "id": "sg:person.0764724735.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764724735.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medical Affairs, Agendia Inc, Irvine, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "de Snoo", 
        "givenName": "Femke A.", 
        "id": "sg:person.01167175573.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167175573.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "The Breast Place, Charleston, SC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Beatty", 
        "givenName": "Jennifer", 
        "id": "sg:person.0652776150.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652776150.11"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1200/jco.2011.36.2574", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006957939"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1155/2014/390618", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010186032"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2217/pme.13.88", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011903621"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-013-2572-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023345920", 
          "https://doi.org/10.1007/s10549-013-2572-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.02.6187", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025932563"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-014-3908-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026850864", 
          "https://doi.org/10.1245/s10434-014-3908-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-014-3908-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026850864", 
          "https://doi.org/10.1245/s10434-014-3908-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-011-1683-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032799097", 
          "https://doi.org/10.1007/s10549-011-1683-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdv221", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036102989"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1602253", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036168635"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(13)62422-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038142448"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(13)62422-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038142448"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(13)62422-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038142448"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(13)62422-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038142448"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2217/fon.09.113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045813783"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-03", 
    "datePublishedReg": "2017-03-01", 
    "description": "PURPOSE: Hormone receptor-positive (HR+) tumors have heterogeneous biology and present a challenge for determining optimal treatment. In the Neoadjuvant Breast Registry Symphony Trial (NBRST) patients were classified according to MammaPrint/BluePrint subtyping to provide insight into the response to neoadjuvant endocrine therapy (NET) or neoadjuvant chemotherapy (NCT).\nOBJECTIVE: The purpose of this predefined substudy was to compare MammaPrint/BluePrint with conventional 'clinical' immunohistochemistry/fluorescence in situ hybridization (IHC/FISH) subtyping in 'clinical luminal' [HR+/human epidermal growth factor receptor 2-negative (HER2-)] breast cancer patients to predict treatment sensitivity.\nMETHODS: NBRST IHC/FISH HR+/HER2-\u00a0breast cancer patients (n\u00a0=\u00a0474) were classified into four molecular subgroups by MammaPrint/BluePrint subtyping: Luminal A, Luminal B, HER2, and Basal type. Pathological complete response (pCR) rates were compared with conventional IHC/FISH subtype.\nRESULTS: The overall pCR rate for 'clinical luminal' patients to NCT was 11\u00a0%; however, 87 of these 474 patients were reclassified as Basal type by BluePrint, with a high pCR rate of 32\u00a0%. The MammaPrint index was highly associated with the likelihood of pCR (p\u00a0<\u00a00.001). Fifty-three patients with BluePrint Luminal tumors received NET with an aromatase inhibitor and 36 (68\u00a0%) had a clinical response.\nCONCLUSIONS: With BluePrint subtyping, 18\u00a0% of clinical 'luminal' patients are classified in a different subgroup, compared with conventional assessment, and these patients have a significantly higher response rate to NCT compared with BluePrint Luminal patients. MammaPrint/BluePrint subtyping can help allocate effective treatment to appropriate patients. In addition, accurate identification of subtype biology is important in the interpretation of neoadjuvant treatment response since lack of pCR in luminal patients does not portend the worse prognosis associated with residual disease in Basal and HER2 subtypes.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1245/s10434-016-5600-x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1105545", 
        "issn": [
          "1068-9265", 
          "1534-4681"
        ], 
        "name": "Annals of Surgical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "24"
      }
    ], 
    "name": "Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping", 
    "pagination": "669-675", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "c058de2c724b01ae480caf6334158afd426280dc6a89ce702ce8ff477a5411d9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27770345"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9420840"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1245/s10434-016-5600-x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1040378989"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1245/s10434-016-5600-x", 
      "https://app.dimensions.ai/details/publication/pub.1040378989"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:35", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70028_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1245%2Fs10434-016-5600-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1245/s10434-016-5600-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1245/s10434-016-5600-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1245/s10434-016-5600-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1245/s10434-016-5600-x'


 

This table displays all metadata directly associated to this object as RDF triples.

351 TRIPLES      21 PREDICATES      74 URIs      55 LITERALS      43 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1245/s10434-016-5600-x schema:about N0116ea2de7b945f99b2b722c5339403f
2 N06ee1322989c47588d450499bf0c4ed3
3 N0e3a82ab14704a3e88e0eb4cc3767faa
4 N13bd8cc751494a4abeef63806ccd1e50
5 N13f10103f41049998bf6ce878f6bcf66
6 N141e459d4a43483093b114b498b7a27e
7 N16f7fc3e5e214e05a8ba0aed22fb689e
8 N19d91420367e472ca69d7ff83ce36014
9 N1f5115389cbb4e208235c82deac5a3bd
10 N262336b90bad4b58b3cd96cf277a79c9
11 N30a9f0143cff4a3f8eedece07fb0d897
12 N3597c8bbe6a14ef48c4fdd8815d45585
13 N4b97527be95640c4810ca3db0d64074f
14 N5292575d3baa4220b33dc26d69569978
15 N53f3120662b9473d9e293352c0f3c4d5
16 N64c0c2150f404c00a623a6578228dda6
17 N6c7ee694aed645a890899591cc345902
18 N77c33bba65d44f42a3999ca477586c7d
19 N78ddd79586104d8bbacf6ea2e88499b8
20 N7e3880f6f79c44aab8762ab7959753a0
21 N8f16d51b42cd49ea9b7f9c28d06fee1b
22 N964abbcc18fc4c1db0c3dddccfb6f525
23 N97247301061244b6a4ea75e5c5e374bd
24 Na9f4c22cdd8442db977e179846154046
25 Nab05bf648f5646728f4e125fa2a1458f
26 Nc95d5d33515341f79c8d672c30c7eddd
27 Ncba87827367e48b89e0db3bb7db15145
28 Ncd49b318569c4b85bf16981a55cb2edb
29 Nd1657edd0b054200ae2bc9461157675d
30 Ndd893ef1fa5f45218475f32e2d3f0db6
31 Ne3577ffb6ddf49d28ddd577b2f4e22b4
32 Nf0a622635c094bf48cc0c6118d52200d
33 Nf1945d19d7b54dad895c52ad2e69510f
34 Nfb782520a1704e488e04f0cc87037487
35 anzsrc-for:11
36 anzsrc-for:1112
37 schema:author Nc92c44733b554075970429842ffa88f0
38 schema:citation sg:pub.10.1007/s10549-011-1683-z
39 sg:pub.10.1007/s10549-013-2572-4
40 sg:pub.10.1245/s10434-014-3908-y
41 https://doi.org/10.1016/s0140-6736(13)62422-8
42 https://doi.org/10.1056/nejmoa1602253
43 https://doi.org/10.1093/annonc/mdv221
44 https://doi.org/10.1155/2014/390618
45 https://doi.org/10.1200/jco.2005.02.6187
46 https://doi.org/10.1200/jco.2011.36.2574
47 https://doi.org/10.2217/fon.09.113
48 https://doi.org/10.2217/pme.13.88
49 schema:datePublished 2017-03
50 schema:datePublishedReg 2017-03-01
51 schema:description PURPOSE: Hormone receptor-positive (HR+) tumors have heterogeneous biology and present a challenge for determining optimal treatment. In the Neoadjuvant Breast Registry Symphony Trial (NBRST) patients were classified according to MammaPrint/BluePrint subtyping to provide insight into the response to neoadjuvant endocrine therapy (NET) or neoadjuvant chemotherapy (NCT). OBJECTIVE: The purpose of this predefined substudy was to compare MammaPrint/BluePrint with conventional 'clinical' immunohistochemistry/fluorescence in situ hybridization (IHC/FISH) subtyping in 'clinical luminal' [HR+/human epidermal growth factor receptor 2-negative (HER2-)] breast cancer patients to predict treatment sensitivity. METHODS: NBRST IHC/FISH HR+/HER2- breast cancer patients (n = 474) were classified into four molecular subgroups by MammaPrint/BluePrint subtyping: Luminal A, Luminal B, HER2, and Basal type. Pathological complete response (pCR) rates were compared with conventional IHC/FISH subtype. RESULTS: The overall pCR rate for 'clinical luminal' patients to NCT was 11 %; however, 87 of these 474 patients were reclassified as Basal type by BluePrint, with a high pCR rate of 32 %. The MammaPrint index was highly associated with the likelihood of pCR (p < 0.001). Fifty-three patients with BluePrint Luminal tumors received NET with an aromatase inhibitor and 36 (68 %) had a clinical response. CONCLUSIONS: With BluePrint subtyping, 18 % of clinical 'luminal' patients are classified in a different subgroup, compared with conventional assessment, and these patients have a significantly higher response rate to NCT compared with BluePrint Luminal patients. MammaPrint/BluePrint subtyping can help allocate effective treatment to appropriate patients. In addition, accurate identification of subtype biology is important in the interpretation of neoadjuvant treatment response since lack of pCR in luminal patients does not portend the worse prognosis associated with residual disease in Basal and HER2 subtypes.
52 schema:genre research_article
53 schema:inLanguage en
54 schema:isAccessibleForFree true
55 schema:isPartOf N0afd6b20762f4c5a9056242eb53e1172
56 Nda18744498684db38984e6811e3e72a6
57 sg:journal.1105545
58 schema:name Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping
59 schema:pagination 669-675
60 schema:productId N2ca7fb1340e64263926c25194bb35280
61 N32c6297ead9b4233b94735a8de20feae
62 N6387065093924ba7a3071f400a95ab38
63 Na996a46ccd074d28b3d9addc1bab2fe4
64 Nf914a2fa4abb42cb933c720dd1721d5c
65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040378989
66 https://doi.org/10.1245/s10434-016-5600-x
67 schema:sdDatePublished 2019-04-11T12:35
68 schema:sdLicense https://scigraph.springernature.com/explorer/license/
69 schema:sdPublisher N3ea7711d5d47484daedeaaeb2db2a7ec
70 schema:url https://link.springer.com/10.1245%2Fs10434-016-5600-x
71 sgo:license sg:explorer/license/
72 sgo:sdDataset articles
73 rdf:type schema:ScholarlyArticle
74 N0116ea2de7b945f99b2b722c5339403f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Middle Aged
76 rdf:type schema:DefinedTerm
77 N06ee1322989c47588d450499bf0c4ed3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Tamoxifen
79 rdf:type schema:DefinedTerm
80 N0afd6b20762f4c5a9056242eb53e1172 schema:issueNumber 3
81 rdf:type schema:PublicationIssue
82 N0e3a82ab14704a3e88e0eb4cc3767faa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Nitriles
84 rdf:type schema:DefinedTerm
85 N132203b1c76543869fb2e882dad331f2 rdf:first sg:person.0762503715.44
86 rdf:rest Nb9b3ed3208914d428518a417d3ec259d
87 N13bd8cc751494a4abeef63806ccd1e50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Chemotherapy, Adjuvant
89 rdf:type schema:DefinedTerm
90 N13c768ba158142adac64088dc8e87cdd rdf:first sg:person.01167175573.05
91 rdf:rest Nc96c6cdd5b814f3a82da3fa4492f13fc
92 N13f10103f41049998bf6ce878f6bcf66 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Clinical Decision-Making
94 rdf:type schema:DefinedTerm
95 N141e459d4a43483093b114b498b7a27e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Molecular Typing
97 rdf:type schema:DefinedTerm
98 N16f7fc3e5e214e05a8ba0aed22fb689e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Taxoids
100 rdf:type schema:DefinedTerm
101 N192341daac2e409b8c8c9bbd91175506 schema:name Virginia Breast Center, Bon Secours Cancer Institute, Richmond, VA, USA
102 rdf:type schema:Organization
103 N19d91420367e472ca69d7ff83ce36014 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Antineoplastic Combined Chemotherapy Protocols
105 rdf:type schema:DefinedTerm
106 N1f5115389cbb4e208235c82deac5a3bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name In Situ Hybridization, Fluorescence
108 rdf:type schema:DefinedTerm
109 N262336b90bad4b58b3cd96cf277a79c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Breast Neoplasms
111 rdf:type schema:DefinedTerm
112 N2ca7fb1340e64263926c25194bb35280 schema:name doi
113 schema:value 10.1245/s10434-016-5600-x
114 rdf:type schema:PropertyValue
115 N2e54f78d7a5e4aa69e9c345d470e5ffe schema:name Department of Medical Affairs, Agendia Inc, Irvine, CA, USA
116 rdf:type schema:Organization
117 N30a9f0143cff4a3f8eedece07fb0d897 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Treatment Outcome
119 rdf:type schema:DefinedTerm
120 N32c6297ead9b4233b94735a8de20feae schema:name pubmed_id
121 schema:value 27770345
122 rdf:type schema:PropertyValue
123 N3597c8bbe6a14ef48c4fdd8815d45585 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Immunohistochemistry
125 rdf:type schema:DefinedTerm
126 N3ea7711d5d47484daedeaaeb2db2a7ec schema:name Springer Nature - SN SciGraph project
127 rdf:type schema:Organization
128 N4b97527be95640c4810ca3db0d64074f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Docetaxel
130 rdf:type schema:DefinedTerm
131 N5292575d3baa4220b33dc26d69569978 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Aged
133 rdf:type schema:DefinedTerm
134 N53f3120662b9473d9e293352c0f3c4d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Bridged-Ring Compounds
136 rdf:type schema:DefinedTerm
137 N5e195f596fb2443eaf1b253ab6d60794 rdf:first sg:person.01343475561.36
138 rdf:rest Ncc12506a7b14406bba645091c14717da
139 N6387065093924ba7a3071f400a95ab38 schema:name readcube_id
140 schema:value c058de2c724b01ae480caf6334158afd426280dc6a89ce702ce8ff477a5411d9
141 rdf:type schema:PropertyValue
142 N64c0c2150f404c00a623a6578228dda6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Receptors, Progesterone
144 rdf:type schema:DefinedTerm
145 N6c64bdf086f944bd9686be07cf22f65c rdf:first sg:person.01151566350.32
146 rdf:rest N132203b1c76543869fb2e882dad331f2
147 N6c7ee694aed645a890899591cc345902 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Aromatase Inhibitors
149 rdf:type schema:DefinedTerm
150 N77c33bba65d44f42a3999ca477586c7d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Registries
152 rdf:type schema:DefinedTerm
153 N78ddd79586104d8bbacf6ea2e88499b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Prospective Studies
155 rdf:type schema:DefinedTerm
156 N7e3880f6f79c44aab8762ab7959753a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Receptors, Estrogen
158 rdf:type schema:DefinedTerm
159 N81bf129358da4f16ba5c9a1de86e8317 schema:name Akron General Hospital, Akron, OH, USA
160 rdf:type schema:Organization
161 N8ad51c845f564d6e83453aef8a5886a9 rdf:first sg:person.0604662750.55
162 rdf:rest N5e195f596fb2443eaf1b253ab6d60794
163 N8f16d51b42cd49ea9b7f9c28d06fee1b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Adult
165 rdf:type schema:DefinedTerm
166 N964abbcc18fc4c1db0c3dddccfb6f525 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Humans
168 rdf:type schema:DefinedTerm
169 N97247301061244b6a4ea75e5c5e374bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Triazoles
171 rdf:type schema:DefinedTerm
172 N9b7b252a4c524a4f8a8b844bc0e339c3 rdf:first sg:person.0767224550.91
173 rdf:rest N6c64bdf086f944bd9686be07cf22f65c
174 Na047f36a38b44875a1bab4d6847bd2db rdf:first sg:person.014031317265.63
175 rdf:rest N8ad51c845f564d6e83453aef8a5886a9
176 Na996a46ccd074d28b3d9addc1bab2fe4 schema:name nlm_unique_id
177 schema:value 9420840
178 rdf:type schema:PropertyValue
179 Na9f4c22cdd8442db977e179846154046 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Aged, 80 and over
181 rdf:type schema:DefinedTerm
182 Nab05bf648f5646728f4e125fa2a1458f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Receptor, ErbB-2
184 rdf:type schema:DefinedTerm
185 Nad70418fde3347ca9626aa1e321287d1 schema:name Coastal Carolina Breast Center, Murrells Inlet, SC, USA
186 rdf:type schema:Organization
187 Nb9b3ed3208914d428518a417d3ec259d rdf:first sg:person.01103453150.10
188 rdf:rest Na047f36a38b44875a1bab4d6847bd2db
189 Nbc2d39e144334f30b7eb9762da077a8f rdf:first sg:person.01150535406.46
190 rdf:rest Ndbbd2ca4622e4a068e25993d68aa9396
191 Nc0c440205fd94f2181cee42e5a30fd7e schema:name Nashville Breast Center, Nashville, TN, USA
192 rdf:type schema:Organization
193 Nc1a314c758ab437ba1fb437f1d2c73c3 schema:name Comprehensive Cancer Center, Palm Springs, CA, USA
194 rdf:type schema:Organization
195 Nc92c44733b554075970429842ffa88f0 rdf:first sg:person.07624156167.68
196 rdf:rest Nbc2d39e144334f30b7eb9762da077a8f
197 Nc95d5d33515341f79c8d672c30c7eddd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Letrozole
199 rdf:type schema:DefinedTerm
200 Nc96c6cdd5b814f3a82da3fa4492f13fc rdf:first sg:person.0652776150.11
201 rdf:rest rdf:nil
202 Ncba87827367e48b89e0db3bb7db15145 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Gene Expression Profiling
204 rdf:type schema:DefinedTerm
205 Ncc12506a7b14406bba645091c14717da rdf:first sg:person.0764724735.42
206 rdf:rest N13c768ba158142adac64088dc8e87cdd
207 Ncd49b318569c4b85bf16981a55cb2edb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
208 schema:name Doxorubicin
209 rdf:type schema:DefinedTerm
210 Nd1657edd0b054200ae2bc9461157675d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Female
212 rdf:type schema:DefinedTerm
213 Nda18744498684db38984e6811e3e72a6 schema:volumeNumber 24
214 rdf:type schema:PublicationVolume
215 Ndbbd2ca4622e4a068e25993d68aa9396 rdf:first sg:person.0620474121.32
216 rdf:rest N9b7b252a4c524a4f8a8b844bc0e339c3
217 Ndd893ef1fa5f45218475f32e2d3f0db6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
218 schema:name Cyclophosphamide
219 rdf:type schema:DefinedTerm
220 Ne226a49689524ac3ab8f696935c3ba25 schema:name St. John Region, Grosse Pointe Woods, MI, USA
221 rdf:type schema:Organization
222 Ne3577ffb6ddf49d28ddd577b2f4e22b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
223 schema:name Mastectomy, Segmental
224 rdf:type schema:DefinedTerm
225 Ne6765831ebc54a3b88fc2a510fd01130 schema:name The Breast Place, Charleston, SC, USA
226 rdf:type schema:Organization
227 Ne836136db67048a1a1980e0db988f2b8 schema:name Department of Medical Affairs, Agendia Inc, Irvine, CA, USA
228 rdf:type schema:Organization
229 Ne8e8631a6eb342b5ad038ae92e42fa5f schema:name Breast and Melanoma Specialists of Charleston, Charleston, SC, USA
230 rdf:type schema:Organization
231 Nf0a622635c094bf48cc0c6118d52200d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
232 schema:name Anastrozole
233 rdf:type schema:DefinedTerm
234 Nf1945d19d7b54dad895c52ad2e69510f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
235 schema:name Young Adult
236 rdf:type schema:DefinedTerm
237 Nf914a2fa4abb42cb933c720dd1721d5c schema:name dimensions_id
238 schema:value pub.1040378989
239 rdf:type schema:PropertyValue
240 Nfb782520a1704e488e04f0cc87037487 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
241 schema:name Neoadjuvant Therapy
242 rdf:type schema:DefinedTerm
243 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
244 schema:name Medical and Health Sciences
245 rdf:type schema:DefinedTerm
246 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
247 schema:name Oncology and Carcinogenesis
248 rdf:type schema:DefinedTerm
249 sg:journal.1105545 schema:issn 1068-9265
250 1534-4681
251 schema:name Annals of Surgical Oncology
252 rdf:type schema:Periodical
253 sg:person.01103453150.10 schema:affiliation Nc1a314c758ab437ba1fb437f1d2c73c3
254 schema:familyName Lee
255 schema:givenName Laura A.
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103453150.10
257 rdf:type schema:Person
258 sg:person.01150535406.46 schema:affiliation https://www.grid.ac/institutes/grid.477059.8
259 schema:familyName Beitsch
260 schema:givenName Peter
261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150535406.46
262 rdf:type schema:Person
263 sg:person.01151566350.32 schema:affiliation https://www.grid.ac/institutes/grid.490329.5
264 schema:familyName Nash
265 schema:givenName Charles
266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151566350.32
267 rdf:type schema:Person
268 sg:person.01167175573.05 schema:affiliation Ne836136db67048a1a1980e0db988f2b8
269 schema:familyName de Snoo
270 schema:givenName Femke A.
271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167175573.05
272 rdf:type schema:Person
273 sg:person.01343475561.36 schema:affiliation Ne8e8631a6eb342b5ad038ae92e42fa5f
274 schema:familyName Baron
275 schema:givenName Paul
276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01343475561.36
277 rdf:type schema:Person
278 sg:person.014031317265.63 schema:affiliation Ne226a49689524ac3ab8f696935c3ba25
279 schema:familyName Dul
280 schema:givenName Carrie L.
281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014031317265.63
282 rdf:type schema:Person
283 sg:person.0604662750.55 schema:affiliation https://www.grid.ac/institutes/grid.492869.8
284 schema:familyName Rotkis
285 schema:givenName Michael
286 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604662750.55
287 rdf:type schema:Person
288 sg:person.0620474121.32 schema:affiliation Nad70418fde3347ca9626aa1e321287d1
289 schema:familyName Mislowsky
290 schema:givenName Angela
291 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620474121.32
292 rdf:type schema:Person
293 sg:person.0652776150.11 schema:affiliation Ne6765831ebc54a3b88fc2a510fd01130
294 schema:familyName Beatty
295 schema:givenName Jennifer
296 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652776150.11
297 rdf:type schema:Person
298 sg:person.07624156167.68 schema:affiliation Nc0c440205fd94f2181cee42e5a30fd7e
299 schema:familyName Whitworth
300 schema:givenName Pat
301 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07624156167.68
302 rdf:type schema:Person
303 sg:person.0762503715.44 schema:affiliation N81bf129358da4f16ba5c9a1de86e8317
304 schema:familyName Murray
305 schema:givenName Mary
306 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762503715.44
307 rdf:type schema:Person
308 sg:person.0764724735.42 schema:affiliation N2e54f78d7a5e4aa69e9c345d470e5ffe
309 schema:familyName Stork-Sloots
310 schema:givenName Lisette
311 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764724735.42
312 rdf:type schema:Person
313 sg:person.0767224550.91 schema:affiliation N192341daac2e409b8c8c9bbd91175506
314 schema:familyName Pellicane
315 schema:givenName James V.
316 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767224550.91
317 rdf:type schema:Person
318 sg:pub.10.1007/s10549-011-1683-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1032799097
319 https://doi.org/10.1007/s10549-011-1683-z
320 rdf:type schema:CreativeWork
321 sg:pub.10.1007/s10549-013-2572-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023345920
322 https://doi.org/10.1007/s10549-013-2572-4
323 rdf:type schema:CreativeWork
324 sg:pub.10.1245/s10434-014-3908-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1026850864
325 https://doi.org/10.1245/s10434-014-3908-y
326 rdf:type schema:CreativeWork
327 https://doi.org/10.1016/s0140-6736(13)62422-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038142448
328 rdf:type schema:CreativeWork
329 https://doi.org/10.1056/nejmoa1602253 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036168635
330 rdf:type schema:CreativeWork
331 https://doi.org/10.1093/annonc/mdv221 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036102989
332 rdf:type schema:CreativeWork
333 https://doi.org/10.1155/2014/390618 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010186032
334 rdf:type schema:CreativeWork
335 https://doi.org/10.1200/jco.2005.02.6187 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025932563
336 rdf:type schema:CreativeWork
337 https://doi.org/10.1200/jco.2011.36.2574 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006957939
338 rdf:type schema:CreativeWork
339 https://doi.org/10.2217/fon.09.113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045813783
340 rdf:type schema:CreativeWork
341 https://doi.org/10.2217/pme.13.88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011903621
342 rdf:type schema:CreativeWork
343 https://www.grid.ac/institutes/grid.477059.8 schema:alternateName Dallas Surgical Group
344 schema:name Dallas Surgical Group, Dallas, TX, USA
345 rdf:type schema:Organization
346 https://www.grid.ac/institutes/grid.490329.5 schema:alternateName Northeast Georgia Medical Center
347 schema:name Northeast Georgia Medical Center, Gainesville, GA, USA
348 rdf:type schema:Organization
349 https://www.grid.ac/institutes/grid.492869.8 schema:alternateName Northern Indiana Cancer Research Consortium
350 schema:name Northern Indiana Cancer Research Consortium, South Bend, IN, USA
351 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...